Clinical Peptide Therapy is a physician-directed approach that supports targeted physiological pathways through carefully selected peptide compounds. Each protocol is prescribed based on medical evaluation, health history, and laboratory findings to ensure clinical appropriateness. Treatments are administered under medical supervision and adjusted over time according to individual response. Ongoing follow-up allows for structured monitoring of safety, tolerability, and measurable physiological outcomes.
Clinical peptide protocols in this category are designed to support fat metabolism, energy utilization, and appetite regulation through targeted metabolic and endocrine pathways. Treatment selection is based on comprehensive medical evaluation, body composition analysis, laboratory findings, and individualized clinical objectives.
These protocols aim to assist in body fat reduction, support metabolic efficiency, and promote sustainable weight management under structured physician supervision. Therapy is continuously monitored and adjusted according to clinical response and patient tolerability to ensure safety and measurable oversight.
Tesofensine, AOD-9604, MOTS-C, Tesamorelin, and lipotropic formulations (Lipo B, Lipo C, Lipo Den), depending on medical assessment and treatment indication.
A physician-guided foundational metabolic support program designed for patients beginning structured fat reduction therapy. This protocol focuses on metabolic activation and lipotropic support under medical supervision.
An enhanced metabolic modulation protocol designed for patients requiring stronger appetite and fat oxidation support. This program integrates multi-pathway metabolic compounds to support more resistant fat loss patterns under structured clinical oversight.
A comprehensive endocrine and metabolic optimization protocol designed for advanced body composition transformation. This structured program integrates fat metabolism modulation, hormonal pathway support, and mitochondrial optimization under close medical supervision.
Clinical peptide protocols in this category are designed to support physiological growth hormone activity and optimize body composition through targeted endocrine pathways. Treatment selection is guided by comprehensive medical evaluation, hormonal profiling, body composition analysis, and defined clinical objectives.
These protocols aim to assist in lean muscle preservation and development, support fat metabolism, and enhance recovery. Therapy is monitored and adjusted based on clinical response, laboratory findings, and patient tolerability to ensure safety and appropriate medical oversight.
CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, and Ibutamoren (MK-677), depending on medical assessment and treatment indication.
A physician-directed hormonal pathway support program designed to assist lean muscle development and metabolic balance. This protocol focuses on optimizing growth hormone–related pathways to support body recomposition, recovery, and age-related metabolic changes.
Clinical peptide protocols in this category are designed to support tissue repair, inflammatory modulation, and physiological recovery processes. Treatment selection is based on medical evaluation, injury history, inflammatory markers, and individual clinical needs.
These protocols may assist in musculoskeletal recovery, soft tissue support, gastrointestinal integrity, and immune modulation. Therapy is monitored and adjusted according to clinical progression and patient response to ensure safety and appropriate medical oversight.
BPC-157, TB-500, GHK-Cu, KPV, and Thymosin Alpha-1, depending on clinical assessment and treatment indication.
A targeted regenerative support program designed to assist tissue repair and inflammation modulation. This protocol is structured for individuals seeking clinical support for musculoskeletal strain, joint discomfort, or gut-related inflammation under medical guidance.
Clinical peptide and compound protocols in this category are designed to support neurocognitive function through targeted modulation of neurological and cellular pathways involved in memory, focus, mood regulation, and mental performance. Treatment selection is based on comprehensive medical evaluation, cognitive health assessment, and individual clinical objectives.
These protocols aim to support mental clarity, emotional balance, and neurological resilience while promoting mitochondrial function and cellular energy production within the central nervous system. Therapy is continuously monitored and adjusted according to clinical response, laboratory findings, and patient tolerability to ensure safety and appropriate medical oversight.
Semax, Selank, Dihexa, Methylene Blue, and NAD+, depending on medical assessment and treatment indication.
A neuro-support program designed to assist cognitive clarity, stress regulation, and mood balance. This protocol supports neurological pathways involved in focus and emotional resilience through physician-directed peptide therapy.
Clinical peptide and compound protocols in this category are designed to support cellular function and energy metabolism through targeted physiological pathways involved in mitochondrial activity, metabolic regulation, and immune modulation. Treatment selection is based on comprehensive medical evaluation, metabolic and immunological profiling, and individual clinical objectives.
These protocols aim to promote cellular resilience, optimize energy production, and support healthy aging processes. Therapy is continuously monitored and adjusted according to clinical response, laboratory findings, and patient tolerability to ensure safety and appropriate medical oversight.
NAD+, MOTS-C, Thymosin Alpha-1 y SLU-PP-332, depending on clinical assessment and treatment indication.
A cellular energy support program designed to assist mitochondrial function and systemic vitality under physician supervision. This protocol integrates metabolic and neurocellular support strategies aimed at energy optimization and healthy aging.
Clinical peptide protocols in this category are designed to support sexual health through targeted modulation of physiological pathways involved in arousal, desire, and neuroendocrine balance. Treatment selection is based on comprehensive medical evaluation, hormonal assessment, and individual clinical objectives.
These protocols aim to assist in the management of changes in libido, support physiological sexual response, and promote overall intimate well-being. Therapy is continuously monitored and adjusted according to clinical response, patient tolerability, and medical appropriateness to ensure safety and optimal care.
PT-141 and Oxytocin, depending on medical assessment and treatment indication.
A physician-guided intimate health protocol designed to support physiological sexual response and neuroendocrine balance. This program focuses on structured evaluation and targeted support for changes in libido and performance.